Beyond IP and Approval in Medtech Innovation with Darcy Bachert, CEO at Prolucid Technologies

Strong medtech innovation is not just about building great technology. It is about solving a real market problem, proving product-market fit, and creating a path to sustainable growth. In this episode, Darcy Bachert, CEO at Prolucid Technologies, joins Saul Marquez at the MedTech Innovator Radar Forum to discuss how medtech companies can bring promising technologies to market. Darcy shares how Prolucid supports organizations across the medical and nuclear sectors, with a strong emphasis on imaging and diagnostics. He reflects on the strength of the MedTech Innovator ecosystem and the momentum of companies progressing through the program with impactful innovations. Darcy also explains that today’s funding environment demands more than IP and regulatory progress; investors want real-world, market-ready, and monetizable solutions. Tune in and learn why medtech companies need to stay close to customers while building technologies that can truly succeed. Resources: Connect with and follow Darcy Bachert on LinkedIn. Follow Prolucid Technologies on LinkedIn and explore their website here.